BackNextCell Pharma AB Overview

NextCell Pharma AB Current Assets

Track NextCell Pharma AB's current assets ($42M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$42.11M

Peer trimmed avg / median

Loading

NextCell Pharma AB Current Assets History

Loading

NextCell Pharma AB vs. peers: Current Assets Comparison

Loading

NextCell Pharma AB Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NextCell Pharma AB (NXTCL.ST) FAQ

NextCell Pharma AB (NXTCL.ST) currently reports a current assets of $42M as of June 2026. Use the charts on this page to explore NextCell Pharma AB's current assets history and peer comparisons.

NextCell Pharma AB reported $42M in current assets as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $42M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NextCell Pharma AB, and consider following NXTCL.ST for alerts when major investors trade the stock.

NextCell Pharma AB is classified in the Healthcare sector. On current assets, it currently shows $42M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NXTCL.ST with unrelated industries.